Zhengye Biotechnology Holding Ltd [ZYBT] stock prices are up 1.55% to $9.16 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ZYBT shares have gain 7.39% over the last week, with a monthly amount drifted -12.18%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Zhengye Biotechnology Holding Ltd [ZYBT] has been fluctuating between $3.50 and $14.30 over the past year. Zhengye Biotechnology Holding Ltd [NASDAQ: ZYBT] shares were valued at $9.16 at the most recent close of the market.
Analyzing the ZYBT fundamentals
The Zhengye Biotechnology Holding Ltd [NASDAQ:ZYBT] reported sales of 26.26M for trailing twelve months, representing a drop of -21.95%. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.21%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.11 and Total Capital is 0.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.01 points at the first support level, and at 6.86 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.87, and for the 2nd resistance point, it is at 10.59.
Ratios To Look Out For
It’s worth pointing out that Zhengye Biotechnology Holding Ltd [NASDAQ:ZYBT]’s Current Ratio is 1.34. As well, the Quick Ratio is 0.81, while the Cash Ratio is 0.1. Considering the valuation of this stock, the price to sales ratio is 16.53, the price to book ratio is 11.15 and price to earnings (TTM) ratio is 153.95.
